Institutional investors purchased a net $405.1 thousand shares of MYGN during the quarter ended June 2016 and now own 118.50% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ACADIAN ASSET MANAGEMENT LLC Bought 2.3 Million shares of Myriad Genetics Inc
CWM LLC Bought 222.7 Thousand shares of Myriad Genetics Inc
FIRST QUADRANT LP Bought 36.6 Thousand shares of Myriad Genetics Inc